MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
148 hedge funds and large institutions have $558M invested in Momenta Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 54 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
26% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 54
Holders
148
Holding in Top 10
1
Calls
$3.89M
Puts
$766K
Top Buyers
| 1 | +$15.3M | |
| 2 | +$6.59M | |
| 3 | +$5.28M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.82M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.75M |
Top Sellers
| 1 | -$8.13M | |
| 2 | -$3.03M | |
| 3 | -$2.99M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.19M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.17M |